Pre-eclampsia-associated alterations in Wharton's jelly proteoglycans

• Autorzy: Gogiel T. , Galewska Z. , Jaworski S.
• Języki publikacji: EN

Abstrakty

EN

Proteoglycans of Wharton’s jelly contain mainly chondroitin/dermatan sulphate chains. The predominant proteoglycan is decorin (core proteins of 45 and 47 kDa), although the core proteins of biglycan (45 kDa), versican (260 kDa) and of other proteoglycans (90, 110, 220 kDa) were also detected (Gogiel et al., 2003). The aim of the present study was to compare the proteoglycan composition of Wharton’s jelly of newborns delivered by healthy mothers and those with pre-eclampsia. Proteoglycans from pre-eclamptic Wharton’s jelly had a higher sulphated glycosaminoglycan/protein ratio than those of normal tissue. Pre-eclampsia is associated with a lower level of all proteoglycan core proteins, especially those of higher molecular mass (such as versican), although the same set of core proteins were found in normal and pre-eclamptic Wharton’s jelly. The alterations in the proteoglycan composition of Wharton’s jelly may affect the mechanical properties of the umbilical cord and, in the case of pre-eclampsia, disturb foetal blood circulation.

Słowa kluczowe

EN

proteoglycan; glycosaminoglycan; Wharton's jelly; pre-eclampsia; umbilical cord

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 2005
• Tom: 52
• Numer: 2
• Opis fizyczny: p.501-505,fig.,ref.

Twórcy

autor

Gogiel T.

• Medical Academy of Bialystok, Bialystok, Poland

autor

Galewska Z.

autor

Jaworski S.

Bibliografia

• Bańkowski E (1999) Collagen of the umbilical cord and its alteration in EPH-gestosis (preeclampsia). Proc Indian Acad Sci (Chem Sci) 111: 207–213.
• Bańkowski E, Romanowicz L, Jaworski S (1993) Collagen of umbilical cord arteries and its alterations in EPH gestosis. J Perinat Med 21: 491–498.
• Barthel-Wottke G, Goee C (1978) EPH-gestose. Übersit und statistise Studie über 2485 Swangere mit Gestose-Zeien. Organisation Gestosis Press, Basel. Delorme MA, Xu L, Berry L, Mitchell L, Andrew M (1998) Anticoagulant dermatan sulphate proteoglycan (decorin) in the term human placenta. Thromb Res 90: 147–153.
• Farndale RW, Sayers CA, Barret AJ (1982) A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 9: 247–248.
• Fisher LW (1999a) Biglycan (BGN). In Guidebook to the Extracellular Matrix, Anchor, and Adhesion Proteins. Kreis T, Vale R, eds, pp 365–368. Sambrook & Tooze, Oxford University Press, London.
• Fisher LW (1999b) Decorin. In Guidebook to the Extracellular Matrix, Anchor, and Adhesion Proteins. Kreis T, Vale R, eds, pp 408–411. Sambrook & Tooze, Oxford University Press, London.
• Fisher LW, Stubbs JT III, Young MF (1995) Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand 66 (Suppl 266): 61–65.
• Gogiel T, Jaworski S (2000) Proteoglycans of the human umbilical cord artery. Acta Biochim Polon 47: 1081–1091.
• Gogiel T, Bańkowski E, Jaworski S (2001) Pre-eclampsia-associated differential expression of proteoglycans in the umbilical cord arteries. Pathobiology 69: 212–218.
• Gogiel T, Bańkowski E, Jaworski S (2003) Proteoglycans of Wharton’s jelly. Int J Biochem Cell Biol 35: 1461–1469.
• Hascall VC, Calabro A, Midura RJ, Yanagishita M (1997) Isolation and characterization of proteoglycans. Methods Enzymol 230: 390–417.
• Howard RB (1987) Control of human placental blood flow. Med Hypotheses; 23: 51–58.
• Iozzo RV, Murdoch AD (1996) Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J 10: 598–614.
• Isogai Z, Shinomura T, Yamakawa N, Takeuchi J, Tsuji T, Heinegard D, Kimata K (1996) 2B1 antigen characteristically expressed on extracellular matrices of human malignant tumors is a large chondroitin sulfate proteoglycan, PG-M/versican. Cancer Res 56: 3902–3908.
• Järveläinen HT, Kinsella MG, Wight TN, Sandell LJ (1991) Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. J Biol Chem 266: 23274–23281.
• Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277: 680–685.
• Nelimarkka L, Kainulainen V, Schönherr E, Moisander S, Jortikka M, Lammi M, Elenius K, Jalkanen M, Järveläinen H (1997) Expression of small extracellular chondroitin/dermatan sulfate proteoglycans is differentially regulated in human endothelial cells. J Biol Chem 272: 12730–12737.
• Pawlicka E, Romanowicz L, Bańkowski E, Chyczewski L, Jaworski S (2002) The effect of pre-eclamptic umbilical cord serum on fibroblast division in culture. Folia Histochem Cytobiol 40: 381–384.
• Romanowicz L, Bańkowski E, Jaworski S (1999a) The activities of some glycosaminoglycan-degrading enzymes in the wall of the umbilical cord artery and their alteration in edema, proteinuria, hypertension (EPH)-gestosis. Clin Chem Lab Med 37: 417–421.
• Romanowicz L, Bańkowski E, Sobolewski K, Jaworski S (1999b) Activities of some glycosaminoglycan-degrading enzymes in Wharton’s jelly and their alteration in EPH-gestosis (Pre-eclampsia). Biol Neonate 76: 144–152.
• Romanowicz L, Bańkowski E, Jaworski S (2000) Stimulation of glycosaminoglycan biosynthesis by umbilical cord serum of newborns delivered by mothers with EPH gestosis (preeclampsia). Pathobiology 68: 264–269.
• Wight TN (1989) Cell biology of arterial proteoglycans. Arteriosclerosis 9: 1–20.
• Yang BL, Zhang Y, Cao L, Yang BB (1999) Cell adhesion and proliferation mediated through the G1 domain of versican. J Cell Biochem 72: 210–220.
• Zor T, Selinger Z (1996) Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Anal Biochem 236: 302–308.